COMPASS THERAPEUTICS INC's ticker is CMPX and the CUSIP is 20454B104. A total of 78 filers reported holding COMPASS THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $7,691,561 | -37.2% | 7,691,561 | +24.3% | 0.03% | -34.7% |
| Q1 2024 | $12,255,311 | +26.3% | 6,189,551 | 0.0% | 0.05% | +11.4% |
| Q4 2023 | $9,702,537 | -20.4% | 6,189,551 | 0.0% | 0.04% | -13.7% |
| Q3 2023 | $12,193,416 | -36.1% | 6,189,551 | +3.1% | 0.05% | -37.8% |
| Q2 2023 | $19,082,353 | +26.3% | 6,000,740 | +29.9% | 0.08% | +32.3% |
| Q1 2023 | $15,110,663 | -35.0% | 4,620,998 | 0.0% | 0.06% | -29.5% |
| Q4 2022 | $23,243,620 | +676964.4% | 4,620,998 | +206.9% | 0.09% | +576.9% |
| Q3 2022 | $3,433 | -99.9% | 1,505,738 | 0.0% | 0.01% | 0.0% |
| Q2 2022 | $3,990,000 | +93.4% | 1,505,738 | 0.0% | 0.01% | +160.0% |
| Q1 2022 | $2,063,000 | -56.8% | 1,505,738 | 0.0% | 0.01% | -58.3% |
| Q4 2021 | $4,773,000 | – | 1,505,738 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Owl Capital Holdings LP | 2,829,712 | $2,829,712 | 0.79% |
| MPM BioImpact LLC | 5,005,086 | $5,005,086 | 0.78% |
| Orbimed Advisors | 22,362,850 | $22,362,850 | 0.44% |
| Vivo Capital, LLC | 3,556,023 | $3,556,023 | 0.33% |
| CM Management, LLC | 310,000 | $310,000 | 0.28% |
| CAXTON CORP | 43,465 | $43,465 | 0.22% |
| Rock Springs Capital Management LP | 5,513,788 | $5,513,788 | 0.17% |
| Cormorant Asset Management, LP | 2,030,823 | $2,030,823 | 0.12% |
| Ground Swell Capital, LLC | 124,394 | $124,394 | 0.10% |
| Monashee Investment Management LLC | 500,000 | $500,000 | 0.06% |